Windtree Therapeutics Inc
NASDAQ:WINT
Windtree Therapeutics Inc
NASDAQ:WINT
Price:
4.49 USD
4.42%
Market Closed
Updated:
May 19, 2024
Windtree Therapeutics Inc
Total Other Income
|
Windtree Therapeutics Inc
Total Other Income Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Windtree Therapeutics Inc
NASDAQ:WINT
|
Total Other Income
-$244k
|
CAGR 3-Years
52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$3.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
-78%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$158m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$55.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Windtree Therapeutics Inc's Total Other Income?
Total Other Income
-244k
USD
-244k
USD
Based on the financial report for Dec 31, 2023, Windtree Therapeutics Inc's Total Other Income amounts to -244k USD.
What is Windtree Therapeutics Inc's Total Other Income growth rate?
Total Other Income CAGR 3Y
52%
52%
The average annual Total Other Income growth rates for Windtree Therapeutics Inc have been 52% over the past three years .
You don't have any saved screeners yet
